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Target predictionSmall non-coding regulatory RNAs (sRNAs) play important roles in regulating gene expression at the
post-transcriptional level and often require the RNA chaperone Hfq. The human opportunistic pathogen
Burkholderia cenocepacia J2315 encodes two distinct RNA chaperones, Hfq and Hfq2. The present work
describes the experimental identiﬁcation and validation of 24 sRNAs from B. cenocepacia J2315, based on
the co-puriﬁcation of sRNAs with the bacterium Hfq protein, followed by conversion into cDNA, cloning,
computational analysis of sequences and validation by Northern blot analysis. The sRNAs here reported
escaped identiﬁcation by previous studies based on transcriptomics or bioinformatic analyses. Results
presented indicate that 3 sRNAs are exclusive to bacteria of the Burkholderia cepacia complex and have
no homologues in other bacteria, while the other 21 share homology, at different extents, to sRNAs of
other bacterial species.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
Over the past years, it has become clear that a variety of proteins and
small non-coding RNAs (sRNAs) have important or essential roles in
regulating gene expression at the post-transcriptional level [1]. sRNAs
can regulate cellular functions as diverse as RNA processing, mRNA
stability, translation, protein stability and secretion [2], although the
precise role of most of them remains unknown [3]. sRNAs play diverse
physiological roles such as the regulation of stress responses and
metabolism, and control of the bacterial envelope composition [4].
sRNAs can act by interacting with a protein target modifying its activity
[5], or base-pair with mRNA targets [6]. Most of the antisense RNAs
base-pairwith targetmRNAswith partial complementarity, modulating
their stability and/or accessibility to the translational machinery [7].
These sRNAs are categorized as either cis- or trans-encoded. The
cis-encoded sRNAs are encoded on the complementary strand of their
target mRNA, thus exhibiting extensive complementarity to the target
[2]. The trans-encoded sRNAs are encoded at chromosomal locations
distinct from the mRNAs that they regulate, generally share little
complementary to their target genes, and often function in association
with the RNA chaperone Hfq [2]. Hfq has been implicated in severaly and Bioengineering, Instituto
ovisco Pais, Torre Sul, Piso 6,
rights reserved.distinct cellular processes such as the control of toxin production,
bioﬁlm formation, quorum-sensing regulators, and type III secretion
system, among others. This RNA chaperone acts by mediating the
base-pairing between the regulatory sRNA and its mRNA target [8].
Burkholderia cenocepacia J2315 is a human opportunistic pathogen
belonging to the Burkholderia cepacia complex (Bcc) (a group of at
least 17 closely related species) [9]. This group of bacteria is particularly
problematic to cystic ﬁbrosis patients, due to the easy patient-to-
patient transmission of epidemic strains, their intrinsic resistance to
the clinically available antibiotics, rendering their eradication virtually
impossible, and the cepacia syndrome, a rapid and fatal necrotizing
pneumonia [10–13]. Unlike most prokaryotes, Bcc bacteria encode
two-distinct Hfq-like proteins [14]. These two Hfq-like proteins, Hfq
and Hfq2, are both required for optimal survival to stress conditions
and for full virulence towards the nematode C. elegans [14]. An in silico
analysis of the genome sequence of B. cenocepacia J2315 predicted 213
putative sRNAs [15]. However, only 4 of these sRNAs, named Bc1 to Bc4,
were experimentally validated [15]. In another study involving a global
transcriptomics approach, 13 sRNAs were found to be expressed,
although none of them matched the previously predicted 213 sRNAs
[16]. In fact, several sRNAs have been experimentally identiﬁed after
large scale screening of bacterial transcriptomes [17–24], and only a
few matched those identiﬁed by computational predictions.
In this work, we present the identiﬁcation and experimental vali-
dation, and in silico characterization of 24 sRNAs from B. cenocepacia
J2315, isolated after co-puriﬁcation with the Hfq RNA chaperone.
None of these 24 sRNAs here described was identiﬁed in previous
transcriptomics or bioinformatics studies. Aiming at the unveiling of
Table 1
Oligonucleotide primers used in this work.
Name Purpose Sequence 5′–3′ Source
5EAO sRNA cloning ATCGtaggcaccugaaa [54]
miRNA
Universal
cloning linker
sRNA cloning AppCTGTAGGCACCATCAddA [54]
3RTO sRNA cloning ATTGATGGTGCCTAC [54]
5LPCRO sRNA cloning ATCGTAGGTGCCTGAAA [54]
3LPCRO sRNA cloning ATTGATGGTGCCTACAG [54]
M13FWD Clone library
screening
TGTAAAACGACGGCCAGT Invitrogen
M13REV Clone library
screening
CAGGAAACAGCTATGACC Invitrogen
5S Northern blot
probe for 5S
rRNA
TTCGGGATGGGAAGGGGTGGGA [14]
BanI restriction endonuclease recognition sequences are underlined. Upper case, DNA;
Lower case, RNA.
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pathogenesis of Bcc bacteria, we performed a search for putative
homologues within the sRNAMap [25] database. We also present
results of the alignment of the sequences of the sRNAs and their
predicted homologues. The predicted secondary structures of the
identiﬁed sRNAs and of their respective predicted homologues are
also shown. To gain further clues on possible functions, a search for
predicted targets using the TargetRNA [26] and the sRNATarget [27]
databases was also performed.
2. Materials and methods
2.1. Bacterial strains and culture conditions
The cystic ﬁbrosis clinical isolate B. cenocepacia J2315 [28] and its
derivative mutant with the hfq gene deleted, B. cenocepacia CJ1 [14]
were used in this study. When in use, the strains were maintained on
PIA plates (Pseudomonas Isolation Agar, Becton Dickinson, New Jersey,
USA), supplemented with 300 mg/L of trimethoprim, as appropriated.
LB medium was used for liquid cultures which were orbitally agitated
(250 rev min−1, 37 °C) using an Agitorb 200 incubator (Aralab,
Portugal). For RNA extraction, 1 ml aliquots of B. cenocepacia J2315
or CJ1 cell suspensions were harvested by centrifugation from
cultures at the early exponential growth phase (2 h), ressuspended
in 250 μL of RNAlater solution (Ambion), and kept at 4 °C until
processed.
2.2. RNA extraction for co-puriﬁcation experiments
Total RNA was extracted from B. cenocepacia cells in RNAlater
solution (Ambion), using the mirVana miRNA isolation kit (Ambion),
followed by acid phenol/chloroform extraction. sRNA (b~400 nt) enrich-
ment was achieved by adjusting the ethanol concentration during RNA
binding to the ﬁber glass, following the manufacturer's instructions.
2.3. Co-puriﬁcation of sRNAs with Hfq
The B. cenocepacia J2315 his-tagged Hfq protein was overproduced
as previously described [29]. Aliquots containing 100 nM of Hfq6
(hexameric form of the protein) were incubated with 1 μg of the
sRNAs fraction (input RNA) at 25 °C for 1 h. Hfq-sRNA complexes were
mixed with 150 μL of 10% Ni-NTA agarose magnetic beads (Qiagen)
and incubated at 25 °C for 1 h, with gentle agitation. Ni-NTA-Hfq-sRNA
complexes were washed with 50 mM phosphate buffer containing
0.05% Tween 20 (wash buffer) and 20 mM of imidazole, and then with
wash buffer containing 200 mM imidazole. Hfq-sRNA complexes were
eluted with 150 mM phosphate containing 500 mM NaCl and 300 mM
imidazole. sRNAs were then acid phenol/chloroform extracted (output
RNA), ethanol precipitated, and ressuspended in 20 μL of high-purity
water (MP Biomedicals).
2.4. cDNA generation for sRNA cloning
Cloning procedures used for sRNAs were based on previously
described methods [30,31], using the 5EAO 5′ oligonucleotide adapter
(Table 1) and themiRNA universal cloning linker (NEB). The procedure
used is schematically represented in Fig. 1. Primers 3RTPO, 3LPCRO
and 5LPCRO (Table 1) were used in reverse transcription and PCR
experiments, respectively. Brieﬂy, sRNAs were dephosphorylated
with CIP (NEB) at 37 °C for 30 min, phenol/chloroform extracted and
ressuspended in 20 μL of high-purity water (MP Biomedicals). sRNAs
were then ligated to the 5′-end of the 5EAO oligonucleotide adapter
with RNA ligase I (NEB) at 25 °C for 2 h. Following phenol/chloroform
extraction and ressuspension in 10 μL of high-purity water (MP
Biomedicals), the sRNAs poolwas 3′ phosphorylatedwith T4polynucle-
otide kinase (NEB) at 37 °C for 15 min, in the presence of 1 mM ATP.Without buffer exchange, the miRNA universal cloning linker (NEB)
was ligated overnight at 20 °C, using the T4 DNA ligase (Fermentas).
sRNA pools were used for reverse transcription (ﬁrst strand synthesis)
using the 3RTPO oligonucleotide primer. Reverse transcription reac-
tions were performed using the First Strand cDNA synthesis kit
(Fermentas), with an incubation of 75 min at 45 °C, in a total volume
of 50 μL. cDNA pools were subsequently treated with RNase H for
30 min at 37 °C, ethanol-precipitated and ressuspended in 5 μL of
high-purity water (MP Biomedicals). The cDNA treated samples were
used in PCR experimentswith the 3LPCRO and 5LPCROoligonucleotides
(Table 1), using TaqMed (Citomed) DNA polymerase. Cycling condi-
tions were as follows: 45 cycles of denaturation at 95 °C for 1 min,
annealing at 55 °C for 1 min, extension at 72 °C for 1 min, and a ﬁnal
extension at 72 °C for 10 min. cDNA pools were then restricted with
BanI (NEB) at 30 °C for 30 min, and phenol extracted. cDNAs where
then concatamerized with T4 DNA ligase (Fermentas) for 16 h at
22 °C, ethanol precipitated, and ressuspended in 5 mM of Tris.Cl (pH
8.0) 10 mMEDTA. Concatamerized cDNAswere poly-A tailed (ﬁlled-in)
with TaqMed (Citomed)DNApolymerase, in the presence of 5 mMATP,
at 72 °C for 30 min. The ﬁnal cDNA concatamerswere puriﬁed using the
Nucleo-spin extract II kit (Nagel-Machery) and eluted in 30 μL of 5 mM
Tris.Cl (pH 8.0).
2.5. cDNA cloning and PCR screening
The resulting cDNA pools were TA-cloned into the pCR 2.1 cloning
vector (Invitrogen) and used to transform E. coli TOP 10F′ cells
(Invitrogen). Transformants were selected on LB plates supplemented
with 50 mg.L−1 kanamycin and 40 mg.L−1 X-gal. White colonies that
originated ampliﬁcation fragments ranging from 250 to 500 bp, after
PCR experiments with the primer pair M13 forward and M13 reverse
(Table 1), were kept for restriction fragment length polymorphism
(RFLP) analysis.
2.6. sRNA clone screening and cDNA sequencing
Analysis of clones by RFLP was performed with HaeIII and BanI,
which allowed the grouping of clones into RFLP groups with unique re-
striction proﬁles, visualized by negative display after ethidium bromide
staining (Gel-doc, Biorad), based on previously describedmethodologies
[32]. One clone representative of each distinct restriction proﬁle was
sequenced, using the M13 forward and M13 reverse primers.
2.7. Northern blot analysis
Validation of sRNA expression was achieved by Northern blot
analysis, using 2 μg of total RNA puriﬁed from cells of B. cenocepacia
Fig. 1. Cloning strategy used in this work. Schematic representation of the strategy used to generate cDNA fragments corresponding to the sRNAs co-puriﬁed with Hfq, cDNA
synthesis and cloning, RFLP proﬁling and sequence analysis of the resulting plasmids.
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RNA was loaded into 10% or 6% 7 M urea polyacrylamide gels and
electrophoresed in 1×TBE buffer at 350 V (45 mA) for 3 h. After
electrophoresis, total RNA was electrotransferred at 20 V, for 16 h at
4 °C using 0.5×TBE buffer to a BrightStar Plus membrane (Ambion,
Madrid, Spain). Probes for each sRNA under study were prepared by
PCR ampliﬁcation of the respective cloned gene, using the primer
pair M13 Forward and M13 Reverse. DNA probes were labeled with
the BrightStar Biodetect kit (Ambion) and puriﬁed using Quick-Spin
columns (Roche). Pre-hybridization and hybridization procedures
were based on previously described methods [14]. The 5S rRNA was
used as loading control in all Northern blot analysis experiments.
Hybridization signals were detected using the BrightStar Biodetect kit(Ambion) and Kodak MX X-ray ﬁlms. The 23S and 16S rRNA bands
were visualized to check RNA quality, after ethidium bromide staining
of 1.5% agarose-formaldehyde gel loadedwith 2 μg of total RNApuriﬁed
from cells of B. cenocepacia J2315.
2.8. Bioinformatics
Nucleotide sequences were 5′- and 3′-clipped at the regions corre-
sponding to the adaptors, prior to bioinformatics analysis. RNA sequence
analysis was achieved using the corresponding cDNA sequences, 5′ and
3′ clipped. Sequences were mapped to the B. cenocepacia J2315 genome
through a BLAST search using the IMG server 3.1 [33,34] and the
B. cenocepacia J2315 genome sequence (Blastn, E-value 1e−50).
Fig. 2. Small-size RNA fractionation and RFLP analysis of cloned sRNAs. (A) Photograph of an 8% 7 M urea polyacrylamide gel loaded with 2 μg of the small-sized RNA fractions used in
co-puriﬁcation experiments, obtained with the mirVanamiRNA kit from B. cenocepacia J2315 cultures, grown for 2 h. The input lane corresponds to the RNA fraction used for interaction
with the histidine-tagged Hfq protein. The output lane corresponds to the RNA bound to Hfq. (B) Photograph of a 10% native polyacrylamide gel loaded with 1 μg of the HaeIII-BanI
digested plasmid DNA obtained from the E. coli clones containing the cDNA derivates of the co-puriﬁed sRNAs. Proﬁle numbers are shown bellow and correspond to the respective Bcj
sRNAs. M, molecular weight markers; nts, nucleotide size.
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in the genomes of other bacteria of the Burkholderiales order was also
performed. For this purpose, sequences corresponding to tRNAs, tmRNAs,
5S and 5.8S rRNA were excluded. Sequences located between or within
open reading frames (ORFs) were kept for further analysis. Blast param-
eters were changed to a maximal number of target sequences of 1000
and the expect threshold to 100, to obtain more distant hits. The word
size was set to 7 in order to improve sensitivity. Sequences matching
the query sequence by at least 99% were retained for further analysis
and mapped to their exact location within the B. cenocepacia J2315
genome.
In order to deﬁne a conserved core sequence of the identiﬁed sRNAs,
the sequences homologous to each sRNA were retrieved from the
genome sequences of the B. cenocepacia strains AU1054, MCO-3,
HI2424 and PC184, and a structural alignment was performed using
the RNAalifold tool from the Vienna RNA Package [35], version 2.0.0
(2010). This structural conservation analysis was extended to all the
Bcc species with their genome sequences available. The presence of pu-
tative promoters (a non-exclusive requirement for a given sRNA) was
predicted using the Virtual Footprint and PRODORIC promoter analysisFig. 3. Genomic location of the Bcj sRNAs. The location of the Bcj sRNAs in chromosome 1, 2 a
are encoded is shown below chromosome 1, in a magniﬁed scale. The direction of the ﬂags
Bcj16. chr, chromosome.server [36] and RNAGENiE [37]. Searches for rho-independent termi-
nators were performed using TransTermHP [38]. The genomic con-
text was determined using the Burkholderia Genome Database [39]
and compared with the E. coli genomic context using the EcoGene
3.0 web interface (http://www.ecogene.org/3.0/). The prediction of
mRNA targets of the sRNAs was performed with the sRNATarget
[27] and the TargetRNA [26] web tools. The E-values considered as
signiﬁcant were those below 0.5. We have used in our blast searches
a minimum seed of 7 nucleotides. A 7 nt segment was previously
reported as being sufﬁcient for efﬁcient target recognition and regu-
lation, and therefore assigning identical functions to homologues of
a speciﬁc sRNA, was based on a minimum of 7 bp seed required for
target binding [40].
3. Results
3.1. Co-puriﬁcation of sRNA with Hfq, cloning and sequencing
In this study we have isolated and puriﬁed sRNAs from the opportu-
nistic human pathogen B. cenocepacia J2315, using a strategy based onnd 3 is shown. Part of chromosome 1 where the sRNAs Bcj2, Bcj7, Bcj9, Bcj16 and Bcj21
indicates the direction of transcription. The asterisk by a ﬂag indicates the location of
143C.G. Ramos et al. / Genomics 101 (2013) 139–148the ability of the Hfq RNA chaperone to bind RNA [14]. Our experimental
approach, summarized in Fig. 1, combines established methodologies,
including total RNA isolation and enrichment in small-sized RNAs, RNA
binding to puriﬁedHfq, conversion of RNA into cDNA, cloning, restriction
fragment length polymorphism (RFLP) analysis with the frequently
cutting endonuclease HaeIII and BanI, sequencing and bioinformatic
analysis.
A total of 356 cloneswere obtained from the pull-down experiments
of RNA with Hfq (Fig. 2A). RFLP analysis of these clones revealed 24
distinct proﬁles (Fig. 2B). A representative clone of each distinct proﬁle
was sequenced.
3.2. Genome location of the Bcj sRNAs
The cDNA sequences corresponding to the sRNA co-puriﬁed with
Hfq were matched to the B. cenocepacia J2315 genome sequence by
blast analysis, using the IMG webserver. Thirteen sRNAs (Bcj1, Bcj2,
Bcj7, Bcj8, Bcj9, Bcj10, Bcj11, Bcj12, Bcj16, Bcj20, Bcj21, Bcj22 and
Bcj23) were located in chromosome 1, 9 in chromosome 2 (Bcj3, Bcj5,
Bcj6, Bcj13, Bcj15, Bcj17, Bcj18, Bcj19 and Bcj24) and 2 in chromosomeTable 2
Comparative genomic analysis of the 24 sRNAs co-puriﬁed with Hfq.
Name
(size nt)
Chromosomal locus Neighbourhood Comments
Bcj1 (624) Chr1: 750384–749792 BCAL0686-sRNA-BCAL0687
→/←/→
Overlaps BCA
Bcj2 (213) Chr1: 1748210–1748516 BCAL1579-sRNA-BCAL1580
←/←/←
5′UTR BCAL15
Bcj3 (277) Chr2: 2165206–165000 oqxA-sRNA-BCAM1948
→/←/→
5′UTR BCAM1
Bcj4 (317) Chr3: 714803–775092 BCAS0676-sRNA-BCAS0678
←/→/←
Overlap ORF B
Bcj5 (797) Chr2: 1590609–1591405 BCAM1428-sRNA-BCAM1429
←/→/←
Intergenic
Bcj6 (427) Chr2: 2723673–2784032 BCAM2436-sRNA-BCAM2437
→/←/→
Intergenic
Bcj7 (252) Chr1: 1718376–1778588 BCAL0264-sRNA-BCAL0265
←/→/←
Intergenic
Bcj8 (144) Chr1: 2229749–2229892 BCAL2019-sRNA-BCAL2020
→/←/→
Intergenic
Bcj9 (219) Chr1: 1780440–1780658 BCALr1625-sRNA-BCAL1626
→/←/→
Intergenic
Bcj10 (161) Chr1: 2441984–2441824 BCAL2210
←
Within revers
Bcj11 (122) Chr1: 1621697–1621819 BCAL1466
→
Overlaps codi
Bcj12 (83) Chr1: 3612418–3612500 BCAL3297
←
Within the re
Bcj13 (314) Chr2: 1026338–1026651 BCAM0928
→
Within the re
Bcj14 (173) Chr3: 865183–865355 BCAS0766
→
Within the re
Bcj15 (317) Chr2: 1753762–1754078 BCAM1573
←
Within the re
Bcj16 (77) Chr1: 1704528–1704604 BCAL1538
→
Within the re
Bcj17 (291) Chr2: 272250–272540 BCAM0223
←
Within the re
Bcj18 (742) Chr2: 1480418–1481159 BCAM1535-sRNA-BCAM1536
←/←/→
Intergenic
Bcj19 (254) Chr2: 7260–7513 BCAM0005A-sRNA-BCAM0006
←/←/→
Intergenic
Bcj20 (416) Chr1: 2711307–2711614 BCAL2448
←
Within the re
the ORF
Bcj21 (756) Chr1: 1704570–1705325 BCAL1538-sRNA-BCAL1539
←/←/→
Within the re
both ORFs
Bcj22 (238) Chr1: 3122254–3122491 BCAL2841
←
Within the re
the ORF
Bcj23 (64) Chr1: 2611209–2611271 BCAL2356-sRNA-BCAL2357
←/←/←
Intergenic
Bcj24 (431) Chr2: 1170963–1171226 BCAM1074
→
Within coding
NA, no data available. EC, E. coli; YP, Y. pestis; ST, S. typhi; SP, S. paratyphi; YE, Y. enterocoliti3 (Bcj4 and Bcj14) (Fig. 3). The exact genome location, nucleotide size
and surrounding genes of each Bcj sRNA are presented in Table 2.
Chromosome 1 harbors the highest density of Hfq co-puriﬁed sRNAs
(an average of 3.35 sRNAs per Mbp), followed by chromosomes 2 (2.79
sRNAs per Mbp) and 3 (2.28 sRNAs per Mbp). It is worth noting that 5
out of the 13 sRNAs encoded in chromosome1 are located in a restricted
location spanning nt 1,700,000–1,800,000 (Fig. 3). Interestingly, the
hfq2 gene, encoding the larger Hfq-like protein in B. cenocepacia J2315
[14], is also located in this genome region (nt 1,704,035–1,704,601),
aswell as the sRNA h2cR, recently described by our research group [41].
3.3. Experimental validation of the Bcj sRNAs
The expression of the 24 sRNAs (Bcj1 to Bcj24) was assessed by
Northern blot analysis. For this purpose, total RNA was extracted from
B. cenocepacia J2315 cells at the early exponential phase of growth
(2 h). We have included in these analyses total RNA extracted from the
B. cenocepacia Δhfq mutant derived from B. cenocepacia J2315 (strain
CJ1 [14]), harvested from cultures at the same growth phase. The exper-
iments using the CJ1 strainwere performed to assess possible regulatoryHomologue
(size nt)
E-value Predicted function
L0687 EC-GlmY
(184)
0.20 Acid response/ regulator of glmS
79 EC-SibC
(141)
1.2 Regulates expression of the toxic
peptide IbsC
948 YP-6S RNA
(183)
1.5 Sequenters sigma70
CAS0677 ST-RttR
(171)
0.39 Unknown
NA NA Unknown
EC-CsrB
(360)
7.9 Antagonist of the CsrA protein
SP-RydB
(68)
5.5 Inhibitor of rpoS
EC-SraF
(188)
0.76 5′UTR of alx (EC) involved in
regulation by pH
EC-MicC
(109)
4.7 Down-regulation of OmpC
e strand of BCAL2210 YE-RtT
(164)
3.4 Unknown
ng sequence NA NA NA
verse strand SP-RyfA
(304)
0.42 Unknown
verse strand YE-RNA II
(520)
1.6 Initiates plasmid replication
verse strand PA-SraF
(180)
3.7 Unknown
verse strand ST-csrB
(363)
6.1 Antagonist of the CsrA protein
verse strand YP-csrC
(254)
0.39 Sequesters CsrA, encode a 13 aa
peptide
verse strand ST-DsrB
(195)
1.6 Regulated by DsrA and HNS,
under control of RpoS
NA NA Unknown
EC-spot 42
(109)
5.5 Regulates DNA pol I and the 6S
RNA
verse strand; overlaps SP-tmRNA
(380)
7.6 Stimulates degradation of defective
mRNAs
verse strand; overlaps PA-rsmB
(348)
3.9 Antagonizing CsrA regulation
verse strand; overlaps EC-CO362
(386)
5.2 Unknown
PA-ryhB2
(97)
1.2 Fur-regulator
sequence omrA/B
(95)
7.9 Downregulate curli gene activator
CsgD
ca; PA, P. aeruginosa.
Fig. 4. Validation of the Bcj sRNAs expression. The expression of the Bcj1 to Bcj24 sRNAs
validated by Northern blot analysis using total RNA samples collected at the early-
exponential (2 h) growth phase from the B. cenocepacia J2315 (wt) and its derivative
mutant with a non-ﬁnctional hfq gene (Δhfq). Blots shown are representative of at least 3
independent experiments.
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blot analysis carried out using 2 μg of RNA (probed using the sRNA
corresponding biotin-labelled cDNA fragments), revealed the presence
of transcripts for each sRNA, clearly conﬁrming the expression of the
24 distinct Bcj sRNAs (Fig. 4).
The relative levels of the transcripts corresponding to the sRNAs
Bcj14, Bcj19 and Bcj21 were similar in the wt and the Δhfq mutant
strain, while the levels of the other sRNAs were distinct in each strain.
In fact, the levels of Bcj1 to Bcj12, Bcj15, Bcj17, and Bcj22 to Bcj24
were lower in the Δhfq strain compared to the wt strain. Contrastingly,
the transcript levels corresponding to Bcj13, Bcj16, Bcj18 and Bcj20
were higher in the Δhfq strain compared to the wt strain. These results
suggest that Hfq either directly or indirectly, affects the levels of 21
out of the 24 sRNAs here described. The mechanisms involved in this
regulation are still unknown.
3.4. In silico search for Bcj sRNAs homologues
The sRNAMap pipeline [25] was used to search for Bcj1 to Bcj24
functional homologues, within all the bacterial genomes with sRNA
annotation available. This software searches homologous seed se-
quences within families of functional sRNAs. This feature represents
a difﬁculty, since little data on functional RNA families is available
for β-proteobacteria [42], being almost absent for bacteria of the
Burkholderiales order [43]. Therefore, using the criteria described
in Section 2.8, we have assigned putative functional homologues
to the identiﬁed Bcj sRNAs. For the sRNAs Bcj5, Bcj11 and Bcj18,
no hits were obtained (Table 2). Homologue sequences with an
E-valueb0.5 could only be found for the sRNAs Bcj1, Bcj4, Bcj12
and Bcj16 (Table 2). Although for the remaining Bcj sRNAs putative
functional homologues could be predicted, the E-values were >0.5
(Table 2). The predicted function of each of the Bcj sRNAs is indicated
in Table 2, assuming a function similar to that of the predicted
functional homologue.
We have also performed the pair-wise alignment of each Bcj sRNA
with the respective homologue (sequences retrieved from the sRNAMap
pipeline) using ClustalW [44] with weighting matrix and neighbor
joining clustering (Supplementary Figs. S1–S24). The predicted second-
ary structures of the Bcj sRNAs (Supplementary Figs. S1–S24) and of
the respective homologue were computed with the RNA Alifold algo-
rithm [45] and rendered with the RNA structure V5.03 software. While
some structural similarity can be easily recognized for the sRNAs Bcj3
and 6S RNA, Bcj20 and the tmRNA, Bcj21 and the RsmB (by structure
super-imposition, using the RNAShapes software, Vienna RNA package
1.5), no other similar structural folding was detected for the other
sRNA/homologue pairs.
3.5. Bcj sRNAs predicted mRNA targets
In order to gain insights into the possible roles played by the Bcj
sRNAs identiﬁed in this work, we have used both the TargetRNA [26]
and sRNATarget [27] programs to predict possible mRNA targets for
each Bcj sRNA. In the case of the TargetRNA software, the genome
sequence available closer to the B. cenocepacia J2315 is the Burkholderia
multivorans ATCC17616 complete genome sequence. Therefore, all
searches using this software were performed within this genome. The
sequence of each predicted target was retrieved and used in a Blast
search to identify the B. cenocepacia J2315 closest homologue. The
P-values associated with the predicted interactions were ﬁltered to
b0.01. Using this criterion, one putative mRNA target for each sRNA
could be predicted, except for Bcj12 and Bcj14, for which no targets
could be predicted by this software (Table 3). Table 3 summarizes the
results obtained for each Bcj sRNA, showing the B. cenocepacia J2315
closest homologue, as well as the predicted hybridization seed.
Multiple putative mRNA targets were predicted by sRNATarget with
a score of 1.0 (Results shown in Supplementary Tables S1–S24). Thissoftware uses a total of 1000 classiﬁers to predict a sRNA–mRNA inter-
action, and a score 1.0 means that all 1000 classiﬁers were used in the
predictionmodel. Only for the sRNA Bcj7, both the programs TargetRNA
and sRNATarget predicted the samemRNA target, hemB. In E. coli, hemB
encodes the phosphobilinogen synthase enzyme activity, involved in
the biosynthesis of heme [46]. No identical targets were predicted by
both programs for any of the other sRNAs.
We have also searched for distinct Bcj sRNAs that have common
predicted mRNA targets. From the data retrieved from the TargetRNA
output (Table 3), no common targetswere identiﬁed. However, analysis
Table 3
Predicted sRNA–mRNA targets interaction.
sRNA Predicted target P-value Hybridization seed
Bcj1 cbiG 0.00057
Bcj2 NusA 0.00428
Bcj3 BCAL1671 0.00075
Bcj4 BCAL0923 9.93e−06
Bcj5 XerD 0.00133
Bcj6 orbF 0.000219513
Bcj7 hemB 1.158e−06
Bcj8 BCAL3397 0.000787637
Bcj9 dtD 0.0061298
Bcj10 BCAL2953 0.000785002
Bcj11 marZ 0.00409435
Bcj12 – – –
Bcj13 BCAM0227 0.000138347
Bcj14 – – –
Bcj15 BCAL1400 0.000301724
(continued on next page)
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Table 3 (continued)
sRNA Predicted target P-value Hybridization seed
Bcj16 BCAM1774 0.000625336
Bcj17 BCAM2496 0.00124302
Bcj18 BCAL1664 0.0014921
Bcj19 BCAL1116 0.00905688
Bcj20 BCAL3397 0.00122053
Bcj21 pBCA093 0.00456211
Bcj22 ruvB 0.000332927
Bcj23 BCAL0110 0.000313855
Bcj24 BCAS0630 0.00035
BCAL1707 (CbiG) – cobalamin biosynthesis protein; BCAL1506 – transcription elongation factor NusA; BCAL1671 – M23B metalopeptidase; BCAL0923 – putative oxidoreductase;
XerD (BCAL2273) – site-speciﬁc tyrosine recombinase; OrbF (BCAL1693) – putative iron transport-related membrane protein; HemB (BCAL0264) – delta-aminolevulinic acid
dehydratase; BCAL3397 – putative phosphatidylglycerophosphatase; DtD (BCAL3343) – D-tyrosyl-tRNA; BCAL2953 – putative prephenate dehydrogenase; MarZ (BCAL3471) –
cell division protein; BCAM0227 – hybrid two-component system kinase-response regulator protein; BCAL1400 – sodium/hydrogen exchanger family protein; BCAM1774 – ABC
transporter ATP-binding protein; BCAM2496 – binding-protein-dependent transport system protein; BCAL1664 – putative cytochrome c-551; BCAL1116 – extracellular
solute-binding protein; BCAL3397 – putative phosphatidylglycerophosphatase; pBCA093 – PIN domain protein; BCAL3339 (RuvB) – holliday junction DNA helicase; BCAL0110 –
putative phage baseplate assembly protein W; BCAS0630 – putative Mn2+ and Fe2+ transporter of the natural resistance-associated macrophage protein family.
The AUG (CUG/GUG) start codon in the target mRNA is underlined. The upper nucleotide sequence in each row refers to the respective Bcj sRNA, and the lower nucleotide sequence
refers to the corresponding predicted mRNA target. Numbers indicate the nucleotide position, in reference to the transcription start site. Dashes represent base-pairing, double dots
represent imperfect base-pairs. Additional targets predicted by the sRNATarget WebServer are listed in Table S1.
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the Bcj8 and Bcj14 sRNAs have two common putative mRNA targets
(Supplementary Tables S8 and S14), BCAL1007 and BCAL2963, both
encoding recO isogene, which product functions with the proteins
RecF and RecR to protect the lagging strand of arrested replication
forks after UV irradiation of E. coli [47].
Analysis of the Bcj8 and Bcj14 sRNA sequences showed that they
share 40% and 46% of homology, respectively, with the SraF sRNA of
E. coli and P. aeruginosa, respectively (Table 2). In E. coli, SraF is part
of the 5′-UTR of the alx mRNA, serving as a pH responsive element[48]. Interestingly, the Bcj8 and Bcj14 sRNAs present 43% of identity
in their nucleotide sequences, although the identity from each of
the Bcj sRNAs differs from those of the SraF sRNA. Furthermore,
neither Bcj8 nor Bcj14 sRNA was predicted to fold into a structure
identical to the structure predicted for the SraF sRNA.
The Bcj6 and Bcj15 sRNAs were found to share 44% and 50% of
homology with the E. coli and S. tiphymurium CsrB sRNAs, respectively
(Table 2). The E. coli CsrB sRNA binds to, and antagonises by seques-
tering, the CsrA protein, a central component of the carbon storage
regulatory system [49]. These Bcj sRNAs present a sequence similarity
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ent from the structure predicted for CsrB (and RsmB). Data from
Tables S6 and S15 also include a common putative mRNA target
for these two sRNAs, tolA (BCAL3202). TolA is an inner membrane
protein that interacts with periplasmic TolB [50] and with the outer
membrane porins OmpC, PhoE and LamB [51]. TolA endows the
coupling of the inner membrane complex, composed of the protein
itself with TolQ and TolR, to the outer membrane complex of TolB
and OprL (also called Pal) [52]. The Tol–Pal complex is required to
maintain the integrity of the outer membrane, being also involved
in uptake of colicins and ﬁlamentous DNA, and implicated in patho-
genesis [53]. Interestingly, the TolR encoding gene is also a predicted
target of the Bcj15 sRNA (Table S15). It is therefore expectable that
these sRNAs play a role on the cell response to stresses affecting the
cell envelope.
4. Discussion
B. cenocepacia has one of the largest prokaryotic genomes [9], and
therefore one would anticipate that its genome encodes a large
number of sRNAs. In fact, Coenye et al. (2007) used computationally
derived predictions and found 213 putative distinct sRNAs in the
genome sequence of B. cenocepacia J2315 [15]. These authors showed
that 21 intergenic regions were up-regulated during growth in
human sputum and conﬁrmed that four of them correlated to the
predicted sRNAs, although only the expression of the sRNA Bc4 was
validated by RT-PCR.
In this work, we have used an approach based on the RNA binding
properties of the Hfq protein [14] to isolate sRNAs that are actively
expressed during the exponential growth phase. This strategy was
designed to directly isolate sRNAs which can then be studied in more
detail, avoiding the large numbers of RNA sequences generated by full
scale screens (Deep-sequencing, transcriptomics [20,22]) that can be
repeated to numbers as high as 70% [22]. The major shortcoming
of our methodology is the fact that those sRNAs that are expressed
only under speciﬁc circumstances and very transiently, will be most
certainly lost. In addition, non-Hfq dependent sRNAs will also bemissed.
Although this strategy can be used to identify mRNA targets whose
regulation is mediated by Hfq-like proteins, no mRNA was obtained.
This most probably derives due to the enrichment step in RNAs of
small size, and by size exclusion of RNAs larger than ~300 nt prior to
the formation of Hfq-RNA complexes. In fact, work in progress in our
lab, using the same strategy, but with fractions of RNAs with sizes
higher than 300 nt, originated a cDNA library with some clones already
identiﬁed as corresponding to speciﬁc mRNAs of B. cenocepacia J2315
(CG Ramos, AM Grilo, JH Leitão, unpublished results).
The strategy employed rendered the identiﬁcation of 24 distinct
sRNAs. Surprisingly, none of the sRNAs matched any of the 213
putative sRNAs previously predicted by Coenye et al. (2007), or the
13 sRNAs identiﬁed using microarrays [16].
Results from the bioinformatics prediction of targets originated a
very limited number of consistent predictions. In fact, only for the
sRNA Bcj7 the two target prediction programs predicted the same
mRNA target, the hemB. Interestingly, the predicted sRNA homologue
of Bcj7 is the RydB sRNA (with an E-value of 5.5) from Salmonella
paratyphi, which is predicted to regulate rpoS. A possible explanation
for the differences in the outputs from the two target prediction
programs used might be the fact that sRNATarget does not allow
searches for putative mRNA targets within the B. cenocepacia J2315
genome sequence. In addition, the vast majority of the sRNAs identi-
ﬁed and functionally characterized so far and deposited in databases
are from E. coli, Salmonella, and other γ-proteobacteria. However,
bacterial species like E. coli and Salmonella have a G+C content of
approximately 50%, quite distinct of the 66.9% G+C of B. cenocepacia
J2315. This difference most certainly contributes to a lower level
of sequence similarity between sRNAs in databases and the sRNAsfrom B. cenocepacia used as queries, independently of the speciﬁc
software used, explaining the low level of conﬁdence achieved in
the identiﬁcation of both homologues and targets.
5. Conclusion
In this study we describe the use of a strategy involving co-
puriﬁcation of sRNAs with the RNA chaperone Hfq, which allowed us
to experimentally identify 24 novel sRNAs in B. cenocepacia J2315.
The identiﬁcation of homologues and putative targets originated
limited information. However, results from mRNA target prediction
for each of the 24 Bcj sRNAs can guide the initial functional character-
ization of these sRNAs.
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